This relationship was more evident in patients who received i.v. magnesium sulfate and may reflect the pharmacokinetic processes involved in i.v. drug delivery. Intravenous magnesium sulfate is ...
Purpose The results of an investigation of serum magnesium concentrations (SMCs) after i.v. versus oral delivery of magnesium in cardiovascular critical care are presented. Results Although ...
Patients with cancer who received IV magnesium on the day of cisplatin administration had significant 27% lower odds of cisplatin-associated AKI compared with those who did not receive IV magnesium.